<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE333nnn/GSE333350/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE333350</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Therapeutic bacteria-trained NK cells confer long-term protection against cancer metastasis</name><description>We report that a single dose of therapeutic Salmonella, a prominent anti-tumor bacterial therapy, provides long-lasting protection against metastasis in mice by inducing trained NK cells. Integrated functional and multi-omics analyses revealed that Salmonella-trained NK (stNK) cells establish an enduring reprogrammed epigenome characterized by enhanced pro-survival signaling and immune effector functions, resulting in more potent IFN-gamma release and cytotoxicity upon secondary stimulation. We further showed that this training requires a transient pulse of IL-12 combined with sustained IL-18 signaling. Crucially, stNK cells significantly outperform conventional immune checkpoint therapies, including PD-1 and TIGIT blockade, in preventing metastasis, underscoring the unique immunological mechanisms in combating metastasis.</description><dates><publication>2026/05/28</publication></dates><accession>GSE333350</accession><cross_references><GSM>GSM9761275</GSM><GSM>GSM9761276</GSM><GSM>GSM9761274</GSM><GSM>GSM9761282</GSM><GSM>GSM9761280</GSM><GSM>GSM9761281</GSM><GSM>GSM9761279</GSM><GSM>GSM9761277</GSM><GSM>GSM9761278</GSM><GPL>23479</GPL><GSE>333350</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>